Showing results (721-730 of 802) with videos related to

Sort By:
Pageof 81
Haematologica|December 3, 2016
Associations between environmental factors and hospital admissions for sickle cell diseaseFrédéric B Piel, Sanjay Tewari, Valentine Brousse, et al.
Oncogene|November 10, 2015
Cytoplasmic PML promotes TGF-β-associated epithelial-mesenchymal transition and invasion in prostate cancerM E Buczek, A K Miles, W Green, et al.
Thrombosis and Haemostasis|December 9, 2016
Real-time dose adjustment using point-of-care platelet reactivity testing in a double-blind study of prasugrel in children with sickle cell anaemiaJoseph A Jakubowski, Carolyn C Hoppe, Chunmei Zhou, et al.
Mayo Clinic Proceedings|October 4, 2011
Health reform: a community experience using design research as a guideMary A Severson, Douglas L Wood, Christine N Chastain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2015
HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression AnalysisTarek M A Abdel-Fatah, Stephanie E B McArdle, Devika Agarwal, et al.
British Journal of Haematology|April 12, 2022
Measurement of erythrocyte membrane mannoses to assess splenic functionHuan Cao, Abhinav Mathur, Charlotte Robertson, et al.
Movement Ecology|February 25, 2015
Flying with the wind: scale dependency of speed and direction measurements in modelling wind support in avian flightKamran Safi, Bart Kranstauber, Rolf Weinzierl, et al.
Journal of Medicinal Chemistry|April 19, 2002
Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationshipsJulia M Adam, D Jonathan Bennett, Anton Bom, et al.
Lancet (London, England)|January 29, 2013
The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trialJo Howard, Moira Malfroy, Charlotte Llewelyn, et al.
Cancer Research|April 5, 2000
Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genesS A Ali, C S McLean, M E Boursnell, et al.
Pageof 81